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Differing Associations of BMI and Body Fat With
Asthma and Lung Function in Children
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Danielle C. Belgrave, MSc, Lesley A. Lowe, PhD, and Clare S. Murray, MD
Summary. Background: Current evidence suggests that in children there is a significant, albeit
weak, association between asthma and obesity. Studies generally use body mass index (BMI) in
evaluating body adiposity, but there are limitations to its use. Method: Children from a population-
based study attending follow-up (age 11 years) were weighed, measured and had percent body
(PBF) and truncal (PTF) fat assessed using bioelectrical impedance. They were skin prick tested
and completed spirometry. Parents completed a validated respiratory questionnaire. Children
were defined as normal or overweight according to BMI and PBF cut-offs. We tested the
association between these adiposity markers with wheeze, asthma, atopy, and lung-function.
Results: Six hundred forty-six children (339 male) completed follow-up. BMI z-score, PBF, and
PTF were all positively associated with current wheeze (odds ratio [95% CI]: 1.27 [1.03, 1.57],
P¼0.03; 1.05 [1.00, 1.09],P¼0.03; 1.04 [1.00, 1.08],P¼0.04, respectively). Similar trendswere
seen with asthma. However, when examining girls and boys separately, significant positive
associations were found with PBF and PTF and asthma but only in girls (gender interaction
P¼0.06 and 0.04, respectively). Associations between being overweight and wheezing and
asthmawere strongerwhen overweight was defined byPBF (P¼0.007, 0.03) thanBMI (P>0.05).
Higher BMI was significantly associated with an increase in FEV1 and FVC, but only in girls.
Conversely, increasing body fat (PBF and PTF) was associated with reduced FEV1 and FVC, but
only in boys. No associations between adiposity and atopy were found. Conclusion: All adiposity
measures were associated with wheeze, asthma, and lung function. However, BMI and PBF did
not have the same effects and girls and boys appear to be affected differently. Pediatr Pulmonol.
2014; 49:1049–1057.  2013 The Authors. Pediatric Pulmonology published by Wiley Periodicals, Inc.
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INTRODUCTION
The UK prevalence of asthma and allergic disease in
children ranks among the highest in the world.1 With a
simultaneous epidemic of childhood obesity,2 associa-
tions between obesity and asthma and atopy have been
suggested. Recent systematic reviews and data from large
epidemiological studies suggest a significant association
between asthma and obesity3–5 but the evidence for an
association between atopy and obesity remains conflict-
ing.6–8While lung function deficits have been observed in
overweight and obese adults,9,10 these findings have not
been universally reported in children.11–14
As most of the studies investigating the association
between asthma/atopy and obesity have used Body mass
index (BMI) as a fat indicator, the results of studies may
reflect the limitation of BMI to predict body adiposity and
health risks in children; BMI can neither distinguishmuscle
mass from fatmass, nor can itmeasure fat distribution.With
a given BMI, girls also have significantly higher amounts of
percentage body fat than boys.15 Although two studies have
used skin fold thickness as direct measure of body fat,16,17
they have shown inconsistent results.
Bioelectrical impedance analysis (BIA) is a relatively
new method to examine body composition. It determines
the electrical impedance, or opposition to the flow of
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a small electrical current through body tissues which
can then be used to calculate an estimate of total
body water. This is then used to estimate fat-free
body mass, and by difference with body weight, body
fat can be derived.18 It is cheap, practical, and non-
invasive. Although BIA has been used in studies
investigating the association between adiposity and
asthma in adults19 it has not yet been used in such
studies in children.
We hypothesize that, within a normal population,
different measures of body adiposity (BMI and body fat
assessed by BIA) will show different associations with
wheeze, asthma, and lung function.
MATERIALS AND METHODS
Study Design, Setting, and Participants
The Manchester Asthma and Allergy Study is a
population-based birth cohort study described in detail
elsewhere.20 Briefly, parents were consented and screened
for eligibility at antenatal clinics. Children were followed
from birth, and attended review clinics at age 1, 3, 5, 8,
and 11–12 years. The study protocol was approved by the
Local Research Ethic Committee, and all parents gave
written informed consent. In this manuscript, we report on
cross-sectional data collected at age 11–12 years.
Data Sources
Clinical follow-up. Participants attended review clinics
at age 11–12 years (mean age 11.5 years, SD 0.5).
Parents completed an interviewer-administered validat-
ed questionnaire.21 Atopic sensitization was ascertained
by skin-prick tests (Dermatophagoides pteronyssinus,
cat, dog, grasses, moulds, milk, and egg; Bayer, Elkahrt,
IN). Lung function was assessed by spirometry and
was measured before (pre-bronchodilator) and 15min
after administration of 400mg of salbutamol (post-
bronchodilator).22
Growth and adiposity measurements. We measured
weight, without shoes or outer clothing (to nearest
0.01 kg), using a weighing scale, and height (to nearest
0.1 cm) using a stadiometer. Percent body fat (PBF) and
percent truncal fat (PTF) were measured by the hand-to-
foot 8-electrode bioelectrical impedance analyzer (Tanita
BC-418, Tokyo, Japan [BIA8]).
Physical development was assessed using diagrams of
Tanner stages23; thesewere developed at the University of
North Carolina’s Population Center and have been
previously validated and successfully used in other cohort
studies.24 Participants were then classified as pre-
pubescent (mean score 1) or peri-pubescent (mean
score >1) according to mean score for pubic hair and
breast/testes development.
Definition of Variables
Current wheeze. Defined as a positive response to the
question “Has your child had wheezing or whistling in the
chest in the last 12 months?”
Current asthma. Defined as history of physician-
diagnosed asthma and wheezing in the last 12 months.
Atopy. Children were skin-prick tested and were
classified as atopic if the weal diameter to any allergen
was 3mm or more greater than the negative control.
Markers of adiposity. BMI was calculated as weight/
height2 (kg/m2).We present BMI as standardized deviation
scores (BMI z-score) using the British Growth Reference
(1990).25 We designated each individual as “normal
weight” or “overweight” using previously published
BMI26 and PBF27 age and gender specific cut-off values.
Lung function. Forced expiratory volume in one second
(FEV1) and forced vital capacity (FVC) were recorded.
Statistical Analysis
Analysis was carried out using SPSS 19 (Chicago, IL).
We used logistic regression to model binary outcomes
(current wheeze, asthma, and atopy). Linear regression was
used to determine the effects of increased body adiposity on
lung function. Confounders with P-value0.1 in univariate
analysis were included in the multivariate analysis.
Within this cohort study, within each gender group, we
have estimated that we have 95% power to detect a
difference in BMI z-score of 0.5 in wheezy boys/girls
compared with non-wheezy boys/girls, at the 5%
significance level. Similarly for PBF and PTF we have
over 80% power to detect a 2% difference between the
groups at the 5% level of significance.
Missing data.Missing data were assumed to be missing
completely at random. Under this assumption, analysis
was carried out only on children with complete data.
Potential confounders. Ethnicity, sex, pre/peri-pubertal
status, breastfeeding, birth weight, gestational age,
parental asthma and atopy, environmental tobacco smoke,
pets, child’s atopy, and socio-economic status (National
Statistics-Socio-economic Classification; http://www.ons.
gov.uk/ons/guide-method/classifications/current-standard-
classifications/soc2010/soc2010-volume-3-ns-sec-rebased-
on-soc2010-user-manual/index.html) were considered as
confounders.
There were no subjects with endocrine disorders or
long-term oral steroid use in the included population.
RESULTS
Study Population
Data were collected on 930 individuals at the age 11-
year review; 104 children prenatally randomized to an
environmental intervention20 were excluded from this
analysis. Of 826 children in the observational cohort, 653
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attended the hospital review and had body fat assessed
using BIA (92 completed postal questionnaires, 81 home
visits); 646 successfully completed BIA measurement
(Fig. 1). There was no significant difference in asthma,
BMI, ethnicity, socio-economic status, birth weight,
gestational age, and parental atopy between children
included and not included in the analysis. Demographics
of the study population are shown in Table 1. There were
clear differences between boys and girls in the prevalence
of asthma and atopy and also in measures of body fat;
subsequent analysis was therefore also conducted in boys
and girls separately.
Association Between Measures of Adiposity and
Clinical Outcomes
Current wheeze. In the univariate analysis, higher BMI
was associated with an increased risk of wheezing (OR
[95% CI]: 1.21 [1.01–1.44], P¼ 0.04); there was no
association between wheeze and PBF or PTF (Table 2).
However, when girls and boys were examined separately,
we found that wheeze in girls was significantly associated
with higher PBF and PTF. In the multivariate analysis,
BMI, PBF and PTF were all significantly associated with
wheeze (Table 3). Although the association between
adiposity andwheeze appeared stronger in girls, therewas
no significant interaction with gender.
When children were classified as overweight or normal
weight according to PBF, the risk of wheeze significantly
increased with being overweight (1.99 [1.32–3.01],
P¼ 0.001; E-Table S1). This remained significant in
the multivariate analysis (P¼ 0.007; Table 4). When boys
and girls were examined separately, overweight girls were
at significantly increased risk of wheeze (2.65 [1.13–
6.23], P¼ 0.03), with no such association found in
boys (1.47 [0.83–2.63], P¼ 0.19). Again, although
inspection of data suggested that the association between
markers of adiposity and wheeze was present in girls,
but not boys, there was no significant interaction with
gender (Table 4).
Current asthma.When stratified by sex, all measures of
body adiposity (BMI, PBF, and PTF) were significantly
higher in girls with asthma; no such associationwas found
in boys (Table 2). In the multivariate analysis, there was a
significant interaction between gender and PTF on the risk
of current asthma (Table 3), in that the risk of asthma
significantly increased with increasing PTF in girls (1.10
[1.02–1.18], P¼ 0.01), with no such association in boys
(1.00 [0.95–1.06], P¼ 0.91).
When children were categorized as overweight or
normal weight according to PBF cut-offs, current asthma
was significantly associated with being overweight (1.73
[1.10–2.83], P¼ 0.02; E-Table S1). After adjustment,
this association remained significant (P¼ 0.03; Table 4).
This association was markedly stronger amongst girls
(P¼ 0.08 for interaction), with odds for overweight girls
having asthma being more than 3-fold higher (3.37 [1.34–
8.48]) higher, and no increase in the risk of asthma among
overweight boys (1.21 [0.61–2.40], Table 4).
Atopy. We found no association between atopy and
increased body adiposity (Tables 1–4, E-Table S1).
Lung function.BMIwas positively associated with FEV1
and FVC (Table 5). These associations were similar both
pre-bronchodilator (E-Table S2) and post-bronchodilator
(Table 5); the strongest relationships were noted for FVC.
When stratified by gender the relationship between BMI
and lung function was only present in girls where
increasing BMI was associated with increased FEV1 and
FVC. No significant associations were seen overall
between PBF and PTF and lung function, either pre or
post bronchodilator (E-Table S2 and Table 5). When boys
and girls were examined separately, no association was
Fig. 1. Consort diagram of data collected at age 11 follow-up visit.
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seen in girls. However, in boys increasing PBF and PTF
resulted in a reduction of both FEV1 and FVC. Pre
bronchodilator, this effect was not significant, but post-
bronchodilator significant reductions were seen in both
parameters such that a 5% increase in PTF was associated
with 35ml/sec reduction in FEV1 and 35mL reduction in
FVC (Table 5).
When examining children with current wheeze, history
of early childhood wheeze, self-reported asthma, and
healthy children separately, similar patterns were ob-
served (data not shown).
DISCUSSION
Key Findings
This is the first study to report significant associations
between increasing body adiposity in children, as
measured by bioelectrical impedance, and asthma,
wheeze, and lung function.
There were marked differences in the prevalence of
asthma and atopy by gender at age 11 years, with both
being significantly more common in boys. Also although
girls had a higher percentage body fat than boys, they
were less likely to be considered overweight by this
parameter, reflecting the differences in normal ranges by
gender.
Importantly, we found no association between adiposi-
ty and atopy. Although for boys there was no association
between measures of adiposity and wheeze or asthma, for
girls adiposity strongly and consistently predicted asthma
and wheeze. The effect size for being overweight by PBF
definition was greater than that seen for being overweight
by BMI criteria. Girls who were overweight by PBF-
defined criteria were more than three times as likely to
have current asthma and 2.5 times more likely to wheeze
than normal-weight girls.
Furthermore, for each 1% increase in body fat, there
was a 10% increase in risk of asthma. However, it is
important to note that these findings are based primarily
on analysis of boys and girls separately and a statistically
significant gender interaction was only found for asthma
and PTF.
For lung function, BMI was significantly associated
with an increase (albeit small) in FEV1 and FVC only in
girls. Conversely, increasing body fat (PBF and PTF) was
associated with reduced FEV1 and FVC, but only in boys.
These effects were evident both before and after the
administration of 400mg of salbutamol, but were only
TABLE 1—Baseline Characteristics of Children Who Attended the Age 11 Review With Impedance Measurements
Overall
(n¼ 646)
Boys
(n¼ 339)
Girls
(n¼ 307) P-Value
Age at follow up [years] 11.43 (0.53) 11.40 (0.55) 11.47 (0.50) 0.10
Anthropometric data
Gestational age [weeks] 39.84 (1.64) 39.76 (1.75) 39.93 (1.51) 0.21
Birth weight [kg] 3.47 (0.51) 3.54 (0.51) 3.40 (0.49) <0.001
Weight [kg] 42.43 (10.10) 41.62 (10.08) 43.32 (10.06) 0.33
Height [cm] 148.1 (7.66) 147.2 (7.78) 149.1 (7.41) 0.002
Body mass index [kg/m2] 19.16 (3.28) 19.01 (3.26) 19.33 (3.31) 0.22
Body mass index z-score 0.50 (1.11) 0.58 (1.11) 0.41 (1.10) 0.044
% Overweight according to BMI (n) 17.6 (114) 17.1 (58) 18.2 (56) 0.63
% Obese according to BMI (n) 5.4 (35) 6.2 (21) 4.6 (14) 0.63
Percent body fat 23.9 (6.19) 22.1 (6.39) 25.9 (5.30) <0.001
% Overweight according to PBF (n) 26.9 (174) 36.3 (123) 16.6 (51) <0.001
% Obese according to PBF (n) 2.9 (19) 4.7 (16) 1 (3) <0.001
Percent truncal fat 18.5 (6.16) 17.5 (6.47) 19.6 (5.59) <0.001
Asthma and atopy
% Atopy sensitization (n) 32.3 (209) 38.1 (129) 26.1 (80) 0.002
% Current wheeze (n) 18.6 (120) 23 (78) 13.7 (42) <0.001
% Current asthma (n) 12.8 (83) 15.9 (54) 9.4 (29) 0.02
Lung function Overall (n¼ 635) Boys (n¼ 333) Girls (n¼ 302) P-Value
Baseline FEV1 [L/sec] 2.32 (0.41) 2.32 (0.41) 2.32 (0.40) 0.87
Baseline FVC [L] 2.69 (0.49) 2.74 (0.52) 2.62 (0.46) 0.002
Overall (n¼ 625) Boys (n¼ 325) Girls (n¼ 300) P-Value
Post-BD FEV1 [L/sec] 2.45 (0.41) 2.47 (0.40) 2.44 (0.41) 0.42
Post-BD FVC [L] 2.73 (0.49) 2.79 (0.49) 2.67 (0.48) 0.003
Pubertal stage Overall (n¼ 544) Boys (n¼ 269) Girls (n¼ 275) P-Value
% Peri-pubertal (n) 80 (436) 80 (216) 80 (220) 0.93
Mean Tanner’s stage 2.04 (0.867) 1.96 (0.795) 2.12 (0.926) 0.03
Data presented as means (standard deviation) for continuous variables or percentage (number) for categorical variables; P-value comparison
between genders, based on t-test for continuous variables and x2-test for categorical variables; bold signifies P< 0.05.
Post-BD, post-bronchodilator.
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statistically significant after bronchodilation. It is note-
worthy that the associations of adiposity were stronger
with post- rather than pre-bronchodilator lung function;
we believe this supports the view that effects of adiposity
on lung function are independent of asthma or wheeze.
Interpretation of Findings
Many previous studies from around the world have
reported that increasing BMI is associated with wheeze
and asthma and that the effect is stronger in girls than
boys.6,12,16,28,29 One study using BIA to assess body fat in
adults reported a significant association between higher
PBF and asthma, but only in women.19 Two pediatric
asthma studies have used skin fold thickness as an
alternative measure of fatness.16,17 Figueroa-Munoz
et al.16 reported no association between the sum of
triceps and sub-scapular skin fold thicknesses and asthma.
Cassol et al.17 used triceps skin fold thickness in
combination with BMI to define obesity and found a
significant positive association with wheeze ever, asthma
TABLE 2—BMI, PBF, and PTF in Relation to Current Wheeze, Asthma, and Atopy
BMI z-Score P-Value PBF P-Value PTF P-Value
Overall
Wheeze, n¼ 120 0.69 (1.17) 0.04 24.38 (6.54) 0.37 19.09 (6.45) 0.21
No wheeze, n¼ 526 0.46 (1.09) 23.82 (6.11) 18.31 (6.09)
Current asthma, n¼ 83 0.70 (1.15) 0.07 24.28 (6.99) 0.58 19.01 (6.83) 0.39
No current asthma, n¼ 563 0.47 (1.10) 23.88 (6.07) 18.38 (6.05)
Atopic, n¼ 209 0.52 (1.18) 0.83 23.90 (6.43) 0.74 18.63 (6.23) 0.78
Non-atopic, n¼ 404 0.50 (1.08) 24.07 (6.14) 18.48 (6.19)
Boys
Wheeze, n¼ 78 0.69 (1.10) 0.35 22.61 (6.23) 0.43 17.77 (6.29) 0.62
No wheeze, n¼ 261 0.55 (1.12) 21.97 (6.44) 17.36 (6.53)
Current asthma, n¼ 54 0.66 (1.06) 0.61 22.06 (6.40) 0.95 17.23 (6.47) 0.79
No current asthma, n¼ 285 0.57 (1.13) 22.13 (6.40) 17.49 (6.48)
Atopic, n¼ 129 0.57 (1.15) 0.61 22.35 (6.38) 0.79 17.69 (6.21) 0.77
Non-atopic, n¼ 190 0.63 (1.10) 22.15 (6.56) 17.47 (6.79)
Girls
Wheeze, n¼ 42 0.69 (1.31) 0.07 27.7 (5.84) 0.02 21.55 (6.07) 0.01
No wheeze, n¼ 265 0.36 (1.06) 25.66 (5.16) 19.26 (5.46)
Current asthma, n¼ 29 0.79 (1.32) 0.05 28.40 (6.19) 0.008 22.31 (6.33) 0.005
No current asthma, n¼ 278 0.37 (1.07) 25.67 (5.14) 19.29 (5.45)
Atopic, n¼ 80 0.45 (1.23) 0.66 26.39 (5.71) 0.38 20.15 (6.00) 0.30
Non-atopic, n¼ 214 0.39 (1.05) 25.78 (5.18) 19.38 (5.47)
Data are presented as mean (standard deviation); P values were calculated using t-test; bold signifies P< 0.05.
TABLE 3—Multivariate Analysis of theAssociationsBetweenWheeze, Asthma, andAtopy andBodyAdiposity (BMI z-Score,
PBF, and PTF)
BMI z-Score PBF PTF
OR [95% CI] P-Value (PInt) OR [95% CI] P-Value (PInt) OR [95% CI] P-Value (PInt)
Overall
Wheeze1 (n¼ 646) 1.27 [1.03–1.57] 0.03 (0.46) 1.05 [1.00–1.09] 0.03 (0.19) 1.04 [1.00–1.08] 0.04 (0.11)
Current asthma1 (n¼ 646) 1.25 [0.99–1.57] 0.06 (0.38) 1.03 [0.99–1.07] 0.16 (0.06) 1.03 [0.99–1.08] 0.12 (0.04)
Atopy2 (n¼ 613) 1.02 [0.97–1.08] 0.39 (0.97) 1.02 [0.99–1.05] 0.21 (0.95) 1.02 [0.99–1.05] 0.19 (0.99)
Boys
Wheeze1 (n¼ 339) 1.17 [0.91–1.51] 0.22 1.02 [0.98–1.07] 0.33 1.02 [0.97–1.06] 0.51
Current asthma1 (n¼ 339) 1.15 [0.86–1.55] 0.35 1.01 [0.96–1.06] 0.75 1.00 [0.95–1.06] 0.91
Atopy2 (n¼ 319) 1.04 [0.84–1.28] 0.74 1.02 [0.98–1.06] 0.34 1.02 [0.98–1.06] 0.33
Girls
Wheeze1 (n¼ 307) 1.40 [0.97, 2.01] 0.07 1.07 [0.99, 1.14] 0.07 1.07 [1.00, 1.14] 0.05
Current asthma1 (n¼ 307) 1.40 [0.93, 2.01] 0.08 1.10 [1.02, 1.18] 0.02 1.10 [1.02, 1.82] 0.01
Atopy2(n¼ 294) 1.03 [0.81, 1.31] 0.82 1.01 [0.97, 1.07] 0.57 1.02 [0.97, 1.07] 0.48
Bold signifiesP< 0.05. OR, odds ratio; 95%CI, 95% confidence interval; PInt: P-value for interaction between BMI z-score/PBF/PTF and gender.
1Adjusted for parental asthma, child’s atopy and gender (where applicable).
2Adjusted for presence of dog at home, maternal and paternal atopy and gender (where applicable).
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ever and severe asthma. To our knowledge, ours is the first
study to assess PBF and PTF using BIA in children and
investigate its association with asthma and wheeze.
Although both higher BMI and PBF predicted asthma in
girls the association between body fat and asthma/wheeze
was stronger than the association with BMI. It is
important to note that BMI cannot distinguish between
and fat and muscle mass and we note that in girls and boys
the relation between body fat and BMI is different.
Girls have higher percentage of body fat for each unit
of BMI (E-Fig. S1). Therefore the association appears
to be between fat (rather than weight) and asthma
in girls; we would therefore advocate the use of fat
measurement as opposed to BMIwhen investigating these
associations.
Previous studies investigating the relationship between
lung function and obesity in children have reported
conflicting results. A population based study of Chinese
school-children aged 6–20 years usingBMI as amarker of
adiposity found similar results to our study, reporting a
positive correlation between BMI and lung function.14 A
US study of mild to moderate asthmatic children aged 5–
12 years also found that increasing BMI was associated
with increases in FEV1 and FVC.
11 Consistent with our
findings, both these studies reported stronger associations
with BMI and lung function in girls.
TABLE 4—Odds Ratios for Asthma, Wheeze, and Atopy in Overweight Children-Multivariate Logistic Regression: Using
Normal Weight as the Reference Category
BMI-defined PBF-defined
OR [95% CI] P-Value (PInt) OR [95% CI] P-Value (PInt)
Overall
Wheeze1 (n¼ 646) 1.51 0.89–2.56 0.13 (0.52) 1.93 1.19–3.11 0.007 (0.26)
Current asthma1 (n¼ 646) 1.65 0.93, 2.94 0.09 (0.21) 1.84 1.07, 3.16 0.03 (0.08)
Atopy2 (n¼ 613) 1.22 0.81–1.84 0.34 (1.00) 1.26 0.85–1.85 0.24 (0.36)
Boys
Wheeze1 (n¼ 339) 1.35 0.70–2.60 0.37 1.47 0.83–2.63 0.19
Current asthma1 (n¼ 339) 1.22 0.57–2.64 0.61 1.21 0.61–2.40 0.58
Atopy2 (n¼ 319) 1.21 0.70–2.10 0.49 1.10 0.68–1.78 0.69
Girls
Wheeze1 (n¼ 307) 1.93 0.81–4.64 0.14 2.65 1.13–6.23 0.03
Current asthma1 (n¼ 307) 2.56 1.03–6.08 0.04 3.37 1.34–8.48 0.01
Atopy2 (n¼ 294) 1.21 0.65–2.25 0.55 1.65 0.86–3.16 0.13
Bold signifiesP< 0.05. OR, odds ratio; 95%CI, 95% confidence interval; PInt: P-value for interaction between BMI z-score/PBF/PTF and gender.
1Adjusted for parental asthma, child’s atopy and gender (where applicable).
2Adjusted for maternal and paternal atopy, dog presence at home and gender (where applicable).
TABLE 5—Associations of Body Adiposity (BMI, PBF, and PTF) With Post-Bronchodilator Lung Function—Multiple Linear
Regression
Overall (n¼ 544) Boys (n¼ 265) Girls (n¼ 279)
b 95% CI P-Value b 95% CI P-Value b 95% CI P-Value
BMI z-score1
FEV1 (L) 0.034 0.013, 0.055 0.002 0.017 0.015, 0.048 0.30 0.036 0.008, 0.065 0.01
FVC (L) 0.059 0.031, 0.087 <0.001 0.021 0.022, 0.063 0.34 0.068 0.034, 0.102 <0.001
BMI2
FEV1 (L) 0.009 0.002, 0.017 0.009 0.005 0.005, 0.015 0.31 0.010 0.001, 0.019 0.03
FVC (L) 0.017 0.007, 0.026 <0.001 0.008 0.006, 0.021 0.26 0.020 0.010, 0.031 <0.001
PBF2
FEV1 (L) 0.003 0.007, 0.001 0.14 0.006 0.011, 0.001 0.02 0.002 0.007, 0.004 0.52
FVC (L) 0.001 0.006 0.004 0.77 0.006 0.013, 0.000 0.06 0.003 0.003, 0.009 0.33
PTF2
FEV1 (L) 0.004 0.007, 0.000 0.05 0.007 0.012, 0.002 0.004 0.002 0.007, 0.003 0.38
FVC (L) 0.002 0.006, 0.003 0.47 0.007 0.014, 0.001 0.02 0.002 0.004, 0.008 0.44
Bold signifies P< 0.05. b, Estimated effect size; 95% CI, 95% confidence intervals.
1Adjusted for pre/peri-pubertal status and height.
2Adjusted for pre/peri-pubertal status, exact age, and height.
Overall Regression also adjusted for gender where appropriate.
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However, in a study of mainly obese children (aged 6–
11 years) FEV1 and FVC were significantly reduced in
overweight/obese children compared to children with
normal weight.12 Another small study of obese children
found no correlation betweenBMI and functional residual
capacity (FRC).13 Neither study examined boys and girls
separately.
The inconsistent findings in the association between
lung function in children and BMI11–13 seems to indicate
that findings are dependent on which population is
studied. If one studies a population in which BMI is
normally distributed, increasing BMI predicts better
lung function. However, when an obese population of
children is studied very high BMI is associated with
poorer lung function, indicating that the relationship
between BMI and lung function may not linear. In our
population, only 35 children were classed as obese
(approx. 5%) and of these only 4 had BMI above 30 kg/
m2 (the usual obese cut-off for adults); the heaviest had a
BMI of 32.9 kg/m2. Thus it is unlikely that our
observations would be the same as those studies of
obese individuals13 or to those with high proportion of
overweight/obese children.12
In contrast to our findings for BMI, we found that for
boys but not girls, increasing PBF and PTF predicted
poorer lung function, where no association was seen for
BMI. It is of note that obese boys deposit fat in the
abdomen, whilst girls deposit fat in the sub-scapular
area.30 Abdominal fat may decrease the expiratory
reserve volume, thus reducing the FVC and FEV1. We
note that for boys in our study the effects on lung function
were greatest for truncal fat.
This study demonstrates that there are different
directions of association for BMI and PBF/PTF and
lung function. It would appear that BMI reflects body
size/growth, rather than fat mass, except perhaps in very
obese children, whereas assessing body fat by bioelectri-
cal impedance may be a better and more specific measure
of fatness itself.
Thus, we would advocate measuring both BMI and
body fat and analyzing genders separately in future
studies of this type.
It is plausible that adiposity effects lung physiology and
disease by different mechanisms. For example, truncal
distribution of adipose tissue could have a mechanical
effect on respiratory physiology as measured by lung
function. It is also well recognized that adipokines for
example leptin acts on inflammatory cells including
eosinophils.31 The gender differences that we have
demonstrated for both symptoms and disease (wheeze
and asthma) and lung function may be the result of both
the amount and/or distribution of adipose tissue. When
approaching puberty, girls tend to have higher body fat
composition than boys for an equivalent BMI.15 This may
mean that the association between increased body
adiposity and asthma and wheeze can be more readily
observed in girls.
It has also been suggested that the increases in estrogen
and progesterone levels during menarche may also play a
role in the gender differences seen.32 In our study mean
Tanner stage was significantly higher in girls than boys.
Strengths and Limitations
The present study used different body adiposity
measures (BMI z-score, PBF, and PTF) to investigate
the association with wheeze, asthma and lung function.
We used BIA to measure PBF and PTF. The 8-electrode
BIA8 device has been shown to have acceptable accuracy
and be a reliable field assessment technique in studies
comparing it with DEXA.33–35 Compared to the
previously used skin-fold thickness method, BIA has
minimal inter-operator variability and causes less
discomfort to the subjects. The raw data are reproducible,
with <1% error on repeated studies.36 A recent study
compared anthropometric measurements to BIA and
showed good correlation between the two37 however, BIA
is quicker and easier to perform.
The use of PBF and PTF in studies of overweight
children may have advantages over just using BMI. They
better indicate fat mass and fat distribution as opposed to
total mass (fat mass andmusclemass). Thus PBF and PTF
can more accurately demonstrate the associations of
body adiposity with risk of outcome. For example, the
increased FEV1 and FVC observed with increased BMI
may well be due to increased muscle mass in those with
higher BMI, or a reflection of increased body growth
resulting in increased lung volumes. When PBF and PTF
were used as markers of adiposity, reduced FEV1 and
FVC were observed.
This study is a cross-sectional study and therefore it is
only able to suggest association rather than causality
between adiposity measures and asthma and lung
function.
International pediatric age/gender specific BMI cut-
offs are well established for defining overweight and
obesity,26 however, pediatric BIA-derived PBF cutoff
values are not available. In order to define overweight/
obese by PBF we used published DEXA-derived PBF
cutoffs.27 Hence our weight classification may have been
influenced by any BIA8–DEXA discrepancies.
35
Although the total number of subjects included in the
study is quite large we acknowledge that the number of
cases is relatively small, particularly when boys and girls
are assessed separately. However, power calculations
show we are sufficiently powered to detect what we
believe to be a clinically significant difference, thus
reducing the type II error.
We adjusted our results for a number of potential con-
founders (Ethnicity, pre/peri-pubertal status, breastfeeding,
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birth weight, gestational age, parental asthma and atopy,
environmental tobacco smoke, pets, child’s atopy, and socio-
economic status). However, we were unable to consider
physical activity and dietary factors in our analysis.
Associations reported between wheeze and current
asthma and BIA measurements appeared to differ
between girls and boys. However, it is important to
note that these findings are based primarily on analysis of
boys and girls separately and a statistically significant
gender interaction was only found for asthma and
PTF, and thus these results should be interpreted with
caution.
CONCLUSION
We found significant associations between body
adiposity (BMI, PBF, and PTF) and wheeze and asthma
at age 11 years, which appeared to be stronger in girls and
also stronger for percent fat than BMI measurements.
BMI and PBF and PTF were significantly associated with
FEV1 and FVC, but the observations were different for
BMI and percent fat. We believe the mechanisms for
the associations demonstrated between adiposity and
wheeze/asthma and lung function are likely to be different
(pro-inflammatory versus mechanical).
This study highlights the differences between BMI and
body fat measurements and also the variation in body fat
between the sexes. Thus for future studies of this type we
would recommend measuring both percent fat and BMI
and investigating gender differences.
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